Zobrazeno 1 - 6
of 6
pro vyhledávání: '"K. M. Petrosyan"'
Autor:
E. V. Borodavina, P. A. Isaev, A. Yu. Shurinov, P. O. Rumyantsev, V. V. Krylov, K. M. Petrosyan, A. D. Kaprin, S. A. Ivanov, S. O. Podvyaznikov, I. S. Romanov, A. M. Mudunov, K. Yu. Slashchuk, R. S. Zhikhorev, M. V. Volkonsky, R. M. Chagova, I. R. Suslova, A. I. Khryapa, A. Kh. Lepshokova, N. L. Fadeeva, A. R. Safarova, L. P. Kaleykina, E. V. Lymar, E. M. Chernyakova, O. A. Snezhko, A. E. Zinkovskaya, F. F. Mufazalov, E. S. Kuzmina, Yu. V. Druzhinina, Sh. I. Musin, M. R. Mukhitova, A. I. Khasanova, S. Z. Safina, S. L. Kirienko
Publikováno v:
Опухоли головы и шеи, Vol 10, Iss 1, Pp 65-72 (2020)
Background. The implementation of tyrosine kinase inhibitors into clinical practice improved treatment outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). Lenvatinib is recommended as a first-line drug for these p
Externí odkaz:
https://doaj.org/article/90b3f88358a64191b3df59c14333279c
Autor:
K. M. Petrosyan, N. V. Severskaya, D. N. Derbugov, A. A. Kuril'chik, N. V. Zhelonkina, A. V. Dement'ev, E. I. Kupriyanova, G. A. Davydov, A. D. Kaprin, V. N. Galkin, S. A. Ivanov
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 5, Iss 1, Pp 96-105 (2018)
Hyperparathyroidism is one of the most common endocrinopathies. This disease leads to a violation of phosphorus-calcium metabolism and the washing out of calcium from bone tissue. Breach of the skeleton’s structure in hyperparathyroidism is often m
Externí odkaz:
https://doaj.org/article/19aaff46f9344d8f85fd5d26b9627086
Autor:
V. V. Krylov, N. S. Legkodimova, T. Yu. Kochetova, V. M. Petriev, M. A. Sigov, V. K. Tishchenko, A. I. Pronin, A. Yu. Shurinov, K. M. Petrosyan, O. N. Spichenkova, O. B. Karyakin, V. A. Biryukov, V. F. Stepanenko, O. P. Vlasova, P. V. Shegaj, S. A. Ivanov, A. D. Kaprin
Publikováno v:
Diagnostic radiology and radiotherapy. 13:75-85
INTRODUCTION: The results of studies of clinical potential of a new domestic radiopharmaceutical 177Lu-DOTA-PSMA in patients with metastatic castration-resistant prostate cancer are presented in this article.OBJECTIVE: The pharmacokinetics, safety an
Autor:
A. A. Rodichev, T. Yu. Kochetova, K. M. Petrosyan, V. V. Krylov, T. M. Geliashvili, E. V. Borodavina, P. I. Garbuzov, A. Yu. Shurinov
Publikováno v:
Diagnostic radiology and radiotherapy. 11:20-24
The latest recommendations of the American Thyroid Association have caused serious disagreements between the nuclear medicine and endocrinologist communities regarding the radioactive iodine use. In 2018 eighteen experts from 8 countries and 4 leadin
Autor:
T Yu. Kochetova, V. V. Krylov, K. M. Petrosyan, O. B. Karyakin, V. A. Biryukov, B. Ya. Alekseev, V. B. Matveev, S. A. Ivanov, A. D. Kaprin
Publikováno v:
Onkourologiâ, Vol 16, Iss 1, Pp 114-123 (2020)
Radiopharmaceuticals previously used to treat patients with metastatic castrate-resistant prostate cancer and skeletal metastases were positioned as means to suppress pain, reduce analgesics consumption and improve the quality of life. They were usua
Autor:
A. I. Khryapa, E. M. Chernyakova, F. F. Mufazalov, E. V. Lymar, S. A. Ivanov, K. Yu. Slashchuk, N. L. Fadeeva, R. M. Chagova, V. V. Krylov, A. R. Safarova, A. M. Mudunov, S. Z. Safina, M. R. Mukhitova, A. I. Khasanova, S. O. Podvyaznikov, K. M. Petrosyan, I. R. Suslova, R. S. Zhikhorev, A. Kh. Lepshokova, P. A. Isaev, S. L. Kirienko, Yu. V. Druzhinina, I. S. Romanov, E. S. Kuzmina, Andrey Kaprin, Sh. I. Musin, O. A. Snezhko, A. Yu. Shurinov, L. P. Kaleykina, A. E. Zinkovskaya, Pavel O. Rumyantsev, M. V. Volkonsky, E. V. Borodavina
Publikováno v:
Opuholi Golovy i Šei, Vol 10, Iss 1, Pp 65-72 (2020)
Background. The implementation of tyrosine kinase inhibitors into clinical practice improved treatment outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). Lenvatinib is recommended as a first-line drug for these p